# Affluent Medical enters strategic collaboration with Edwards Lifesciences for Kalios ring

Affluent Medical signed a cooperation agreement with Edwards Lifesciences covering an exclusive option on Kalios technology, a non-exclusive license for mitral valve replacement IP, and an equity stake. Edwards will pay a total of €15 million in prepayments.

- Type: Partnership
- Announced: 2024-07-13
- Value: $16.4M (15.0M EUR)
- Status: announced
- Products: Kalios adjustable mitral annuloplasty ring, mitral valve replacement technology
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Affluent Medical](https://endata.com/companies/78572.md)
- [Edwards Lifesciences](https://endata.com/companies/5656.md) (partner)

## Sources

- [vcbeathealth.com](https://www.vcbeathealth.com/article/11980), 2024-07-13: "We are proud to sign these agreements with the global leader in structural heart innovation."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.